View Older Stories View More Recent Stories
-
Notable Analyst Rating Changes 11/21: (WDC) (MS) (HOTT) Upgraded; (RIMM) (TGT) (WAG) Downgraded
-
Liberty Media (LINTA) Ready to Make a Move on Sirius (SIRI) Stake
-
Lazard Capital Starts RPX Corp (RPXC) at Buy
-
Lazard Capital Downgrades Activision Blizzard (ATVI) to Neutral
-
Notable ETF Movers of the Day 11/18: (MOO) (FXE) (XLF) Higher; (UNG) (EWZ) (SMH) Lower
-
Notable Analyst Rating Changes 11/18: (SIRI) (HPQ) (AMR) Upgradedl (CEDC) (LEN) (DRI) Downgraded
-
Lazard Starts Ag Stocks: MOS, CF, AGU, POT at Buy, IPI at Neutral
-
Sirius (SIRI) Shares on the Move Following Lazard Upgrade
-
Lazard Capital Upgrades Edwards Lifesciences (EW) to Buy
-
Notable Analyst Rating Changes 11/10: (CSCO) (VRTX) (ASH) Upgraded; (SD) (WEN) (AONE) Downgraded
-
Lazard Capital Starts STEC, Inc. (STEC) at Buy
-
Lazard Capital Starts OCZ Technology Group (OCZ) at Neutral
-
Imperva (IMPV) IPO Surges Higher
-
Lazard Capital Downgrades Targacept (TRGT) to Neutral
-
Delphi Automotive (DLPH) Sees IPO Price of $22 to $24/Share
-
Lazard Capital Upgrades Fluor (FLR) to Buy
-
Lazard Capital Upgrades Rubicon Technology (RBCN) to Buy
-
Notable ETF Movers of the Day 11/04: (VXX) (TAN) (UNG) Higher; (SPY) (FXE) (XLF) Lower
-
Notable Analyst Rating Changes 11/04: (FSLR) (CVS) (MCHP) Upgraded; (FTR) (CHS) (COH) Downgraded
-
First Solar (FSLR) volatility elevated at 83 on wide share price movement
-
Lazard Capital Upgrades First Solar (FSLR) to Buy
-
Lazard Capital Starts Tenneco (TEN) at Buy
-
Lazard Capital Downgrades Thermo Fisher Scientific (TMO) to Neutral
-
Lazard (LAZ) Posts Mixed Q3 Results
-
Trading Radar for 10/27: Exxon (XOM), Dow Chemical (DOW), Baidu.com (BIDU), Procter & Gamble (PG), AMD (AMD) Report
-
Lazard (LAZ) Declares $0.16 Quarterly Dividend; 2.7% Yield
-
Lazard Capital Downgrades Waters Corp. (WAT) to Neutral
-
While Most Analysts Concerned with First Solar (FSLR), Piper Jaffray Says Co. Now in 'Good Hands'
-
Lazard Cuts First Solar (FSLR) to Hold
-
Lazard Capital Upgrades UPS (UPS) to Buy
-
Lazard Capital Upgrades FedEx (FDX) to Buy
-
Lazard Capital Starts LinkedIn (LNKD) at Neutral
-
Lazard Capital Starts Electronic Arts (ERTS) at Buy
-
Lazard Capital Starts Activision Blizzard (ATVI) at Buy
-
Lazard Capital Starts Take-Two Interactive (TTWO) at Neutral
-
Lazard Capital Starts Glu Mobile (GLUU) at Buy
-
Lazard World Dividend & Income (LOR) Declares $0.0753 Monthly Dividend; 8% Yield
-
Notable Mergers and Acquisitions of the Day 10/17: (KMI)/(EP) (ANDS) (STO)/(BEXP) (AGP)/(ETP)
-
Lazard Capital Downgrades Cimarex Energy (XEC) to Neutral
-
Anadys Pharmaceuticals (ANDS) Acquired by Roche for $3.70/Share, 256% Premium
-
Notable Analyst Rating Changes 10/14: (ADTN) (GMCR) (AMP) Upgraded; (NCMI) (GPS) (ECL) Downgraded
-
Lazard Capital Starts Gen-Probe (GPRO) at Neutral
-
Lazard Capital Downgrades National CineMedia (NCMI) to Neutral
-
Lazard (LAZ) Appoints Richard Whitney as Global Co-Head of Chemicals Group
-
Lazard Capital Upgrades Zoll Medical (ZOLL) to Buy
-
Lazard Capital Upgrades Transcept Pharmaceuticals (TSPT) to Buy, $22 Price Target
-
Notable Mergers and Acquisitions of the Day 10/03: (PPDI) (INTC) (ACIW)/(SONE) (AGCO)
-
Carlyle, H&P to Acquire PPD (PPDI) in $3.9B Deal
-
NFL Decision Weighing on B-Dub's (BWLD) Earnings Prospects for 2012
-
Lazard Capital Downgrades MedQuist Holdings (MEDH) to Neutral

